The NEURAPRO Biomarker Analysis: Long-Chain Omega-3 Fatty Acids Improve 6-Month and 12-Month Outcomes in Youths at Ultra-High Risk for Psychosis
Version 2 2024-06-05, 11:20Version 2 2024-06-05, 11:20
Version 1 2021-05-10, 16:04Version 1 2021-05-10, 16:04
journal contribution
posted on 2024-06-05, 11:20authored byGP Amminger, B Nelson, C Markulev, HP Yuen, MR Schäfer, M Berger, N Mossaheb, M Schlögelhofer, S Smesny, IB Hickie, GE Berger, EYH Chen, L de Haan, DH Nieman, M Nordentoft, A Riecher-Rössler, S Verma, A Thompson, Alison YungAlison Yung, PD McGorry
The NEURAPRO Biomarker Analysis: Long-Chain Omega-3 Fatty Acids Improve 6-Month and 12-Month Outcomes in Youths at Ultra-High Risk for Psychosis